期刊
EXPERIMENTAL CELL RESEARCH
卷 331, 期 2, 页码 257-266出版社
ELSEVIER INC
DOI: 10.1016/j.yexcr.2014.12.021
关键词
Endothelial monocyte-activating; polypeptide-II; Blood-tumor barrier; Permeability; PKC-zeta; PP2A; Occludin
资金
- Natural Science Foundation of China [81372682, 81172197, 81171131, 81272564, 81272795, 81372484]
- Natural Science Foundation of Liaoning Province in China [201102300]
- Liaoning Science and Technology Plan Projects [2011225020]
- Shenyang Science and Technology Plan Projects [F11-264-1-15, F12-277-1-05, F13-318-1-16, F13-318-1-19, F13-220-9-15]
- Shengjing Hospital [201304]
Our previous study demonstrated that low-dose endothelial monocyte-activating polypeptide-II (EMAP-II) induces blood tumor barrier (BTB) opening via the RhoA/Rho kinase/protein kinase C (PKC)-alpha/beta signaling pathway and that PKC-zeta is involved in this process via other mechanisms. In the present study, using an in vitro BTB model, we detected the exact signaling mechanisms by which PKC-zeta activation affects EMAP-II-induced BTB hyperpermeability. Our results showed that three types of serine/threonine (Ser/Thr) protein phosphatases (PPs), namely PP1, PP2A, and PP2B, were expressed by rat brain microvascular endothelial cells (RBMECs). There was an interaction between PKC-zeta and PP2A in RBMECs. In addition, EMAP-II induced a significant increase in both the expression and the activity of PP2A in RBMECs. Inhibition of PKC-zeta with PKC-zeta pseudosubstrate inhibitor (PKC-zeta-PI) completely blocked EMAP-II-induced PP2A activation. Conversely, inhibition of PP2A with okadaic acid (OA) had no effect on EMAP-II-induced PKC-zeta activation. Like PKC-zeta-PI, OA partially prevented EMAP-II-induced BTB hyperpermeability and occludin redistribution in RBMECs. Neither PKC-zeta-PI nor OA affected EMAP-II-induced phosphorylation of myosin light chain and redistribution of actin cytoskeleton in RBMECs. Taken together, our present study demonstrated that low-dose EMAP-II increases BTB permeability by activating the PKC-zeta/PP2A signaling pathway, which consequently leads to the disruption of TJs and impairment of endothelial barrier function. (C) 2015 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据